Insulin Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Insulin Market Report is Segmented by Product Type (Rapid-Acting Insulin, Combination Insulin, Long-Acting Insulin, and Others), Application (Type 1 Diabetes and Type 2 Diabetes), Delivery Device (Pens, Infusion Pumps, Syringes, and Others), and Geography (North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa). The Report Offers Market Sizes and Forecasts for all the Above Segments in Terms of Value (USD).

Insulin Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Insulin Drugs Market Size

Insulin Drugs Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 29.04 Billion
Market Size (2030) USD 35.11 Billion
CAGR (2025 - 2030) 3.87 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration High

Major Players

Clinical Laboratory Services Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Human Insulin Drugs Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Insulin Drugs Market Analysis

The Human Insulin Drugs Market size is estimated at USD 29.04 billion in 2025, and is expected to reach USD 35.11 billion by 2030, at a CAGR of 3.87% during the forecast period (2025-2030).

The factors driving the Insulin Market include the rising prevalence of diabetes, the increasing number of novel insulin product launches, and growing government initiatives to create awareness about diabetes.

Diabetes is a chronic (long-lasting) health condition that affects insulin-mediated glucose intake into the cells. Hence, diabetes patients must take insulin daily to maintain blood glucose levels. The rising prevalence of diabetes cases propels the growth of the Human Insulin Market. For instance, according to a 2022 update from the International Diabetic Federation (IDF), the number of individuals living with diabetes is estimated to reach 643 million by 2030 and 783 million by 2045. The significant increase in diabetes and the massive role of insulin in managing this disease is expected to boost the growth of the Global Insulin Market over the forecast period.

The growing government initiatives to create awareness about diabetes and insulin use are also expected to drive the Insulin Market during the forecast period. In November 2023, WHO launched a campaign with an Access to Diabetes Care theme to raise awareness about diabetes and minimize the risk of complications by detection and proper treatment. Raising awareness about diabetes prevention and treatment options is expected to drive the Insulin Market.

The development of various insulin delivery systems is anticipated to boost market growth. For instance, in March 2024, researchers funded by the EU are working on an alternative method to deliver insulin without needles, contributing to the Non-Injectable Insulin Market. The project, called BuBble Gun, aims to deposit liquids into the skin and other soft tissues using compression. This five-year project, slated to conclude by the end of 2024, seeks to develop a needle-free insulin delivery system. These Insulin Delivery Devices are likely to ease the intake of insulin amongst the aging population.

Thus, the factors mentioned above, including the rising prevalence of diabetes, the increasing number of novel insulin product launches, and growing government initiatives to create awareness about diabetes and insulin use, are expected to drive the Insulin Market Value over the forecast period.

Insulin Drugs Industry Overview

The Insulin Market is highly consolidated, with three major manufacturers holding significant Insulin Market Share by Company, and the remaining manufacturers confined to other local or region-specific manufacturers.

The competitive landscape includes an analysis of several well-known international and local companies that hold market shares, including some of the Biggest Insulin Companies like Novo Nordisk A/S, Sanofi, Eli Lilly and Company, Biocon Limited, and Pfizer Inc.

Insulin Drugs Market Leaders

  1. Novo Nordisk A/S

  2. Eli Lilly and Company

  3. Pfizer Inc.

  4. Sanofi

  5. Biocon

  6. *Disclaimer: Major Players sorted in no particular order
Insulin Drugs Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Insulin Drugs Market News

  • May 2024: KT significantly expanded its KT Health Line by introducing two products specifically designed for diabetes care: the Continuous Glucose Monitor Patch and the Insulin Pump Patch.
  • October 2023: Novo Nordisk, a pharmaceutical company based in Denmark, is preparing to conduct phase-III trials for its latest insulin injection, IcoSema, in India. The Drug Controller General of India (DCGI) gave approval to evaluate the effectiveness and safety of this new drug, specifically designed to circulate the blood sugar levels in patients diagnosed with type-two diabetes.

Insulin Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Diabetes
    • 4.2.2 Growing Government Initiatives to Create Awareness About Diabetes
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Requirements for Product Approval
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Product Type
    • 5.1.1 Rapid-Acting Insulin
    • 5.1.1.1 Insulin Lispro
    • 5.1.1.2 Insulin Aspart
    • 5.1.1.3 Insulin Glulisine
    • 5.1.1.4 Technosphere insulin
    • 5.1.2 Combination Insulin
    • 5.1.2.1 NPH/Regular
    • 5.1.2.2 Protamine/Lispro
    • 5.1.2.3 Protamine/Aspart
    • 5.1.3 Long-Acting Insulin
    • 5.1.3.1 Insulin Detemir
    • 5.1.3.2 Insulin Glargine
    • 5.1.3.3 Insulin Glargine-yfgn
    • 5.1.3.4 Insulin Degludec
    • 5.1.4 Others
  • 5.2 By Application
    • 5.2.1 Type 1 Diabetes
    • 5.2.2 Type 2 Diabetes
  • 5.3 By Delivery Device
    • 5.3.1 Pens
    • 5.3.2 Infusion Pumps
    • 5.3.3 Syringes
    • 5.3.4 Others
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes Population (2021-2029)
  • 6.2 Type-2 Diabetes Population (2021-2029)

7. COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Novo Nordisk A/S
    • 7.1.2 Sanofi
    • 7.1.3 Eli Lilly and Company
    • 7.1.4 Biocon
    • 7.1.5 Pfizer Inc.
    • 7.1.6 Wockhardt
    • 7.1.7 Julphar
    • 7.1.8 Sedico
    • 7.1.9 Insulet Corporation
    • 7.1.10 Tonghua Dongbao
  • *List Not Exhaustive

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments.
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Insulin Drugs Industry Segmentation

As per the scope of the report, insulin is defined as a hormone that regulates the body's blood sugar level. It treats chronic diseases such as type 1 and type 2 diabetes. 

The insulin market is segmented by product type, application, delivery device, and geography. By product type, the market is segmented into rapid-acting insulin, combination insulin, long-acting insulin, and other product types. By application, the market is segmented by type 1 diabetes and type 2 diabetes. By delivery device, the market is segmented into pens, infusion pumps, syringes, and other delivery devices. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (USD) for all the above segments.

By Product Type Rapid-Acting Insulin Insulin Lispro
Insulin Aspart
Insulin Glulisine
Technosphere insulin
Combination Insulin NPH/Regular
Protamine/Lispro
Protamine/Aspart
Long-Acting Insulin Insulin Detemir
Insulin Glargine
Insulin Glargine-yfgn
Insulin Degludec
Others
By Application Type 1 Diabetes
Type 2 Diabetes
By Delivery Device Pens
Infusion Pumps
Syringes
Others
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Insulin Market Research FAQs

How big is the Human Insulin Drugs Market?

The Human Insulin Drugs Market size is expected to reach USD 29.04 billion in 2025 and grow at a CAGR of 3.87% to reach USD 35.11 billion by 2030.

What is the current Human Insulin Drugs Market size?

In 2025, the Human Insulin Drugs Market size is expected to reach USD 29.04 billion.

Who are the key players in Human Insulin Drugs Market?

Novo Nordisk A/S, Eli Lilly and Company, Pfizer Inc., Sanofi and Biocon are the major companies operating in the Human Insulin Drugs Market.

Which is the fastest growing region in Human Insulin Drugs Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Human Insulin Drugs Market?

In 2025, the North America accounts for the largest market share in Human Insulin Drugs Market.

What years does this Human Insulin Drugs Market cover, and what was the market size in 2024?

In 2024, the Human Insulin Drugs Market size was estimated at USD 27.92 billion. The report covers the Human Insulin Drugs Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Human Insulin Drugs Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Insulin Industry Report

The global insulin market is segmented by product type, type, and geography, offering comprehensive market analysis and insights into market share and market size. Traditional human insulins, basal or long-acting insulins, bolus or fast-acting insulins, insulin combinations, and biosimilar insulins are among the key product types analyzed. The report provides an industry analysis that highlights the market trends and the growth rate of the industry.

The industry report delves into the market segmentation, examining the market value and market forecast for various regions including North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America. The market overview and market outlook sections offer a detailed understanding of the industry's dynamics, with insights into the largest companies and market leaders in the insulin market.

Industry research and industry reports indicate that the insulin market is influenced by factors such as the prevalence of diabetes and advancements in insulin delivery devices like syringes, pens, and pumps. The report pdf includes a thorough market review and market predictions, providing valuable market data for stakeholders.

The report also covers the industry size and industry statistics, giving a clear picture of the market's current state and future prospects. Industry trends and market growth are discussed in detail, offering an in-depth look at the factors driving the market. The industry outlook section provides a forward-looking perspective on the market's potential, supported by industry information and research from leading research companies.

In summary, this report example offers a comprehensive market analysis and industry outlook, with detailed insights into market segmentation, market value, and market growth. The report provides valuable industry information and industry trends, making it an essential resource for stakeholders in the global insulin market.